Amerge (naratriptan) for migraines
Glaxo is now marketing Amerge (naratriptan) for migraines.It's a new oral "triptan"...similar to Imitrex (sumatriptan).
The big difference is that Amerge is longer-acting because ithas a longer half-life.
This means that recurrent headaches are less likely withAmerge than with Imitrex. About 40% of patients using Imitrex haverecurrent headaches because of its short half-life.